¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Hereditary retinal dystrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • central retinal artery
    ¸Á¸·Á߽ɵ¿¸Æ
  • falciform retinal fold
    ³´¸ð¾ç¸Á¸·ÁÖ¸§
  • geographic retinal atrophy
    Áöµµ¸ð¾ç¸Á¸·À§Ãà
  • giant retinal tear
    °Å´ë¸Á¸·Â°Áü
  • horseshoe retinal tear
    ¸»¹ß±Á¸Á¸·Â°Áü
  • hydraulic retinal reattachment
    ¼ö¾ÐÀÌ¿ë¸Á¸·ÀçÀ¯Âø¼ú
  • massive retinal gliosis
    °ú´ë¸Á¸·½Å°æ¾Æ±³Áõ, °ú´ë¸Á¸·½Å°æ±³Áõ
  • nonrhegmatogenous retinal detachment
    ºñ¿­°ø¸Á¸·¹Ú¸®
  • normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • progressive outer retinal necrosis
    ÁøÇ༺¿Ü¸Á¸·±«»ç
  • retinal
    1. ¸Á¸·- 2. ·¹Æ¼³¯
  • retinal apoplexy
    ¸Á¸·µÈÃâÇ÷, ¸Á¸·Á¹Áß
  • retinal artery
    ¸Á¸·µ¿¸Æ
  • retinal asthenopia
    ¸Á¸·´«ÇÇ·Î
  • retinal break
    ¸Á¸·¿­°ø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary spastic paraplegia
    À¯Àü°æÁ÷ÇϹݽŸ¶ºñ
  • hereditary tubulointerstitial nephritis
    À¯Àü´¢¼¼°ü»çÀÌÁúÄáÆÏ¿°
  • abnormal retinal correspondence
    ÀÌ»ó¸Á¸·´ëÀÀ
  • central retinal artery
    ¸Á¸·Á߽ɵ¿¸Æ
  • retinal apoplexy
    ¸Á¸·µÈÃâÇ÷
  • retinal artery
    ¸Á¸·µ¿¸Æ
  • retinal asthenopia
    ¸Á¸·´«ÇÇ·Î
  • blood-retinal barrier
    Ç÷¾×¸Á¸·À庮
  • retinal break
    ¸Á¸·¿­°ø
  • cystic retinal tuft
    ³¶Æ÷¸Á¸·¼ú
  • normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • retinal concussion
    ¸Á¸·ÁøÅÁ
  • retinal correspondence
    ¸Á¸·´ëÀÀ
  • retinal cryopexy
    ¸Á¸·³Ãµ¿À¯Âø¼ú
  • nonrhegmatogenous retinal detachment
    ºñ¿­°ø¸Á¸·¹Ú¸®
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • hereditary deforming chondrodysplasia
    À¯Àü(¼º) º¯Çü¼º ¿¬°ñ ÀÌÇü¼º(Áõ)(ë¶îîàõܨû¡àõæãÍéì¶û¡à÷ñø).
  • hereditary deforming chondrodysplasia
    À¯Àü(¼º) º¯Çü¼º ¿¬°ñÀÌÇü¼º(Áõ).
  • hereditary dentin hypoplasia
    À¯Àü¼º »ó¾ÆÁú Çü¼ººÎÀü(Áõ)(¡­ßÚä³òõû¡à÷ÝÕîï ñø).
  • hereditary disease
    À¯Àüº´.
  • hereditary disorder
    À¯Àü¼ºÀå¾Ö
  • hereditary disorder
    À¯Àü¼º Àå¾Ö<Áúº´>
  • hereditary ectodermal dysplasia
    À¯Àü¼º ¿Ü¹è¿±¼º ÀÌÇü¼ºÁõ(¡­èâÛÏç¨àõì¶û¡à÷ ñø).
  • hereditary ectodermal polydysplasia
    À¯Àü(¼º) ¿Ü¹è¿±¼º ´Ù¹ßÀÌÇü¼ºÁõ.
  • hereditary edema
    À¯Àü¼º ºÎÁ¾.
  • hereditary edema
    À¯Àü¼º ºÎÁ¾
  • hereditary effect
    À¯ÀüÀû¿µÇâ
  • hereditary elliptocytosis
    À¯Àü¼ºÅ¸¿ø±¸Áõ
  • hereditary enamel hypoplasia
    À¯Àü¼º ¹ý³¶ Áú ÀúÇü¼ºÁõ.
  • hereditary epilepsy
    À¯Àü¼º °£Áú(¡­ÊÖòð).
  • hereditary fragility of bone
    À¯Àü¼º °ñ Ãë¾àÁõ (¡­Íéöªå°ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • limb girdle dystrophy
    Áö´ëÇüÀÌ¿µ¾çÁõ(ò¶Óáû¡ì¶ç½å×ñø).
  • limb-girdle muscular dystrophy
    Áö´ëÇü±ÙÀÌ¿µ¾çÁõ(ò¶ÓáúþÐÉì¶ç½å×ñø)
  • macular corneal dystrophy
    ¹ÝÁ¡°¢¸·ÀÌ¿µ¾çÁõ.
  • macular corneal dystrophy
    ¹ÝÁ¡°¢¸·ÀÌ¿µ¾ç(Áõ)
  • map-dot-fingerprint dystrophy
    ¹«´Ì°¢¸·ÀÌ¿µ¾ç(Áõ), ¹®¾ç°¢¸·ÀÌ¿µ¾ç(Áõ)
  • median nail dystrophy
    Á¤Áß¼Õ¹ßÅéÀÌ¿µ¾ç(Áõ)
  • metachromatic dystrophy
    ÀÌ¿°¼º ÀÌ¿µ¾çÁõ(ì¶æøàõì¶ç½å×ñø).
  • metachromatic dystrophy
    ÀÌ¿°¼º ÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø)
  • microcystic corneal dystrophy
    ¼Ò³¶Æ÷°¢¸·ÀÌ¿µ¾ç(Áõ)
  • muscle dystrophy
    ±ÙÀÌ¿µ¾çÁõ.
  • muscle dystrophy
    ±ÙÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø)
  • muscle dystrophy
    ±ÙÀÌ¿µ¾çÁõ.
  • muscle dystrophy
    ±Ù ÀÌ¿µ¾çÁõ(ÐÉì¶ç½å×ñø).
  • muscular dystrophy
    ±ÙÀÌ¿µ¾çÁõ(¡­ì¶ç½å×ñø)
  • muscular dystrophy
    ±ÙÀÌ¿µ¾çÁõ(ÐÉì¶ç½å×ñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CRA central retinal artery; Chinese restaurant asthma; chronic rheumatoid arthritis; constant relative a...
CRAD central retinal artery occlusion
CRAO central retinal artery occlusion
CRB chemical, radiological, and biological; congenital retinal blindness
CRP chronic relapsing pancreatitis; corneal-retinal potential; coronary rehabilitation program; C-reacti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CMD Congenital myotonic dystrophy
DMD Duchene muscular dystrophy
DMD Duchenne type muscular dystrophy
DM Dystrophy
EDMD Emery-Dreifuss Muscular Dystrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hereditary porphyria cutanea tarda
    À¯Àü¼º ¸¸¹ß¼º ÇǺΠÆ÷¸£ÇǸ°Áõ
  • hereditary syphilis
    ¼±Ãµ ¸Åµ¶
    µ¿ÀǾî=congenital sy
  • hereditary telangiectasia
    À¯Àü¼º ¸ð¼¼Ç÷°ü È®ÀåÁõ
    ¼±ÃµÀûÀ¸·Î ¸ð¼¼Ç÷°üÀÌ È®ÀåµÇ´Â ÁúȯÀ¸·Î °üÂû ½Ã ¹ÝÁ¡»ó È«¹ÝÀ¸·Î ³ªÅ¸³ª°í °³º°ÀûÀ¸·Î È®ÀåµÈ Ç÷°ü ¾ç»óÀ» °üÂûÇÒ ¼ö ÀÖ´Ù.
  • lebers hereditary optic neuropathy
    ·¹¹ö¾¾ ¼±Ãµ¼º ½Ã½Å°æº´Áõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
adult pseudohypertrophic muscular dystrophy Muscular dystrophy of late onset, often in the second or third decade, with relatively mild course; X-linked recessive inheritance; perhaps allelic with Duchenne's dystrophy, but milder and not a genetic lethal.
Compare: Duchenne dystrophy.
Synonym: Becker type tardive muscular dystrophy.
(05 Mar 2000)
Albright's hereditary osteodystrophy An inherited form of hyperparathyroidism associated with ectopic calcification and ossification and skeletal defects, notably the small fourth metacarpals, but intelligence is normal. There are dominant, recessive and X-linked forms.
See: pseudohypoparathyroidism.
Synonym: Albright's syndrome.
(05 Mar 2000)
angioedema, hereditary A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioneurotic oedema.
(12 Dec 1998)
angioneurotic oedema, hereditary A genetic form of angioedema. (Angioedema is also referred to as Quinke's disease.) Persons with it are born lacking an inhibitor protein (called C1 esterase inhibitor) that normally prevents activation of a cascade of proteins leading to the swelling of angioedema. Patients can develop recurrent attacks of swollen tissues, pain in the abdomen, and swelling of the voice box (larynx) which can compromise breathing. The diagnosis is suspected with a history of recurrent angioedema. It is confirmed by finding abnormally low levels of C1 esterase inhibitor in the blood. Treatment options include antihistamines and male steroids (androgens) that can also prevent the recurrent attacks. Also called hereditary angioedema.
(12 Dec 1998)
Barnes' dystrophy A rare type of muscular dystrophy, in which muscles are often hypertrophic and stronger than normal, but later become weak and atrophic.
(05 Mar 2000)
Becker's muscular dystrophy An X-linked inherited disorder characterised by slowly progressive muscle weakness of the legs and pelvis. Other symptoms and findings include increased difficulty walking, intellectual retardation, fatigue and pseudohypertrophy of the calf muscles.
(27 Sep 1997)
Becker type muscular dystrophy A muscular dystrophy that has many of the clinical features of Duchenne muscular dystrophy e.g., symmetrical involvement of first the pelvicrural muscles and then the pectoral girdle and proximal upper extremity muscles; pseudohypertrophy, especially of the calf muscles but with a much later age of onset (35-45 years), and more benign course. X-linked inheritance.
(05 Mar 2000)
Becker type tardive muscular dystrophy Muscular dystrophy of late onset, often in the second or third decade, with relatively mild course; X-linked recessive inheritance; perhaps allelic with Duchenne's dystrophy, but milder and not a genetic lethal.
Compare: Duchenne dystrophy.
Synonym: Becker type tardive muscular dystrophy.
(05 Mar 2000)
benign pseudohypertrophic muscular dystrophy <neurology> An X-linked inherited disorder characterised by slowly progressive muscle weakness of the legs and pelvis. Other symptoms and findings include increased difficulty walking, intellectual retardation, fatigue and pseudohypertrophy of the calf muscles.
(06 Aug 1998)
canine hereditary blindness An autosomal dominant condition seen in dogs of the collie and several other breeds.
(05 Mar 2000)
macular dystrophy A group of disorders involving predominately the posterior portion of the ocular fundus, due to degeneration in the sensory layer of the retina, retinal pigment epithelium, Bruch's membrane, choroid, or a combination of these tissues.
See: Stargardt's disease, Best's disease.
(05 Mar 2000)
map-dot-fingerprint dystrophy Fingerprint dystrophy accompanied by map-like patterns and microcystic epithelial inclusions.
(05 Mar 2000)
reflex sympathetic dystrophy A syndrome of pain and tenderness, usually to a hand or foot, associated with vasomotor instability, skin changes and rapid development of bony demineralisation (osteoporosis). Frequently will follow a localised trauma, stroke or peripheral nerve injury.
(27 Sep 1997)
reflex sympathetic dystrophy syndrome <syndrome> A condition that features a group of typical symptoms, including pain (often burning type), tenderness, and swelling of an extremity associated with varying degrees of sweating, warmth and/or coolness, flushing, discoloration, and shiny skin.
(12 Dec 1998)
vitreo-tapetoretinal dystrophy Autosomal recessive bilateral peripheral and central retinoschisis with pigmentary degeneration of the retina, chorioretinal atrophy, vitreous degeneration, and night blindness.
Synonym: Favre's dystrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á